Ensign Peak Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-30,860
Closed -$144K 2261
2021
Q4
$144K Buy
+30,860
New +$144K ﹤0.01% 1997